We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Moves Against Cesium Chloride As Bulk Substance in Compounded Drugs
FDA Moves Against Cesium Chloride As Bulk Substance in Compounded Drugs
The FDA announced on Monday that it will take enforcement action against compounders using the unapproved bulk substance cesium chloride, partially granting a December 2017 petition by Public Citizen.